🇺🇸 FDA

Company profile · Sponsor

Neuroscience

Neuroscience Trials Australia

C634420 · NMPA pharma CN
Pipeline
5
Drugs
0
Patents
0

Quick answer

Neuroscience (C634420) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C634420
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (5)

Search pipeline →

  1. Direct endovascular clot retrieval

    Neuroscience

    Ischemic Stroke

    phase 3 other completed

    1 trial

  2. Tissue Plasminogen Activator (Alteplase)

    Neuroscience

    Stroke

    phase 3 small molecule completed

    1 trial

  3. Bone marrow derived stem cells

    Neuroscience

    Spinal Cord Injury

    phase 2 other active

    1 trial

  4. Tenecteplase

    Neuroscience

    Ischemic Stroke

    phase 2 small molecule completed

    1 trial

  5. Tranexamic Acid

    Neuroscience

    Intracerebral Haemorrhage

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is Neuroscience?

Neuroscience (C634420) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Neuroscience sponsor?

We track 5 ClinicalTrials.gov-linked programs for Neuroscience, including Direct endovascular clot retrieval and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Neuroscience company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.